Benefits and Challenges of Successfully Implementing the Direct to Patient Model
- Date:
- 24 October 2018
- Time:
- -
The attendee will be able to:
- Describe two (2) benefits each for the clinical site, sponsor and patient of a direct to patient trial
- Identify at least two (2) risks for sponsors and develop an effective mitigation strategy for these risks
- Identify two (2) late stage customization strategies that can support delivery of medication closer to the patient thus minimizing waste
